Autism Investor Summit |April 1-3, 2024| Beverly Hills

PROUD SPONSOR

Speaking: Dexter Braff

Autism Services M&A: Down, But Not Out

At last year’s conference, we noted the beginnings of a falloff in autism services M&A – down from a record breaking 46 transactions posted in 2019, but not by much as in each of the past three years, we recorded 41-43 transactions. Headwinds were gathering from many directions, but it was unclear how the sector would hold up. A year later, it’s clear that after an extraordinary 5-year run, autism services M&A has taken a hit. In this session, we will discuss why activity has stumbled, how autism has performed compared to other health care sectors and the broad market as a whole, the outlook for 2024, and initiatives prospective sellers can execute now to take advantage of the inevitable rebound.

Braff Attendees:

Nancy Weisling, Senior Advisor

Steve Garbon, Managing Director

Ted Jordan, Managing Director


WEBINAR: Trends and Transactions in Healthcare Services M&A

April 22, 2024 1:00 PM EST

M&A deal activity in payer, provider, and healthcare services is expected to increase significantly in 2024. The panel will discuss current sector trends, such as provider acquisitions by large healthcare service companies, opportunities to acquire financially and operationally stressed companies, non-core asset sales, macroeconomic and regulatory environment, capital availability and role of technology and AI as deal catalysts.

Panelists:

Dexter Braff, The Braff Group

Dana Jacoby, Vector Medical Group

Alex Kasdan, Convergence


Capital + Strategy |April 11 | Washington, D.C.

PROUD SPONSOR

Speaking: Mark Kulik

After the Fall: Will Home Health and Hospice M&A Rebound in 2024?

You likely know that home health and hospice M&A was down substantially in 2023. So, the question shining brightly is will it come back? But first, why did it fall off in the first place? Was it a referendum on buyers’ interest in the space? If a rebound is in the offing, how long will it take? What could derail it? And what does the trendline look like regarding valuations?

Braff Attendees:

Kris Novak, Managing Director

Barrett Kulik, Associate 


Treatment Center Investment & Valuation Retreat – East|April 15-17 | Palm Beach Gardens, FL

PROUD SPONSOR

Speaking: Dexter Braff

Behavioral Health M&A: Back or Blue?

At TCIV West, we were in the midst of a down market. Rising interest rates, inflation, staffing shortages, valuation fatigue, and fear of a recession had taken its toll on a heretofore Teflon market. But there were reasons to be optimistic. Easing of the capital markets. The real possibility of an economic “soft landing”. Slowing inflation. Pent-up demand. In this session, we take stock of where the addiction treatment M&A market currently stands. Has it continued to slide, arrested its decline, or perhaps regained its mojo? What’s happening in valuation? And what can we expect in the next 6-12 months?

Braff Attendees:

Nancy Weisling, Senior Advisor

Steve Garbon, Managing Director

Ted Jordan, Managing Director

Juli Knox, Research & Development


Home Care Innovation Forum | May 19- 21 | Napa, CA

PROUD SPONSOR

Braff Attendees:

Dexter Braff, President

Mark Kulik, Senior Managing Director

Kris Novak, Managing Director

Barrett Kulik, Associate 


CAHSAH | May 21 – 23 | Rancho Mirage, CA

Braff Attendee:

Kris Novak, Managing Director


Elevate Conference | June 13 | Washington, D.C.

PROUD SPONSOR

Speaking: Kris Novak

Braff Attendees:

Mark Kulik, Senior Managing Director

Kris Novak, Managing Director

Barrett Kulik, Associate 


Elevate Conference | July 21 – 22 | Las Vegas, NV

Braff Attendees:

Mark Kulik, Senior Managing Director

Barrett Kulik, Associate 


FUTURE Conference | August 21 – 23 | Nashville, TN

PROUD SPONSOR

Speaking: Dexter Braff

Braff Attendees:

Dexter Braff, President

Mark Kulik, Senior Managing Director

Kris Novak, Managing Director

Barrett Kulik, Associate